{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "## Data Exploration"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "s3_bucket_path=\"s3://aegovan-data/human_output/human_keyinteractions.json\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import boto3\n",
    "\n",
    "def download_single_file(bucket_name_path, local_path):\n",
    "    index = bucket_name_path.find(\"://\")\n",
    "\n",
    "    # remove the s3:// if present\n",
    "    if index > -1:\n",
    "        bucket_name_path = bucket_name_path[index + 3:]\n",
    "\n",
    "    key_start_index = bucket_name_path.find(\"/\")\n",
    "    bucket_name = bucket_name_path\n",
    "    key = \"/\"\n",
    "    if key_start_index > -1:\n",
    "        bucket_name = bucket_name_path[0:key_start_index]\n",
    "        key = bucket_name_path[key_start_index + 1:]\n",
    "        \n",
    "    client = boto3.resource('s3')\n",
    "    client.Bucket(bucket_name).download_file(key, local_path)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_file=\"input_data.json\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "download_single_file(s3_bucket_path, data_file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of records: 3381\n"
     ]
    }
   ],
   "source": [
    "\n",
    "import pandas as pd\n",
    "\n",
    "data = pd.read_json(data_file)\n",
    "\n",
    "print(\"Total number of records: {}\".format(data.shape[0]))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Sneak preview of the data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [],
   "source": [
    "#TODO: Fix data format\n",
    "data[\"pubmedId\"] = data[\"pubmedId\"].astype(str)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2503510</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_huma...</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR fa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2503513</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_huma...</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR fa...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1796163</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_hum...</td>\n",
       "      <td>25500533</td>\n",
       "      <td>None</td>\n",
       "      <td>LRRK2, a gene relevant to Parkinson's disease,...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "    interactionId  interactionType isNegative  \\\n",
       "0         2503510  phosphorylation      false   \n",
       "1         2503513  phosphorylation      false   \n",
       "10        1796163  phosphorylation      false   \n",
       "\n",
       "                                         participants  pubmedId pubmedTitle  \\\n",
       "0   [{'uniprotid': 'P43405', 'alias': [['ksyk_huma...  25605870        None   \n",
       "1   [{'uniprotid': 'P43405', 'alias': [['ksyk_huma...  25605870        None   \n",
       "10  [{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_hum...  25500533        None   \n",
       "\n",
       "                                       pubmedabstract  \n",
       "0   NLRP3 is the most crucial member of the NLR fa...  \n",
       "1   NLRP3 is the most crucial member of the NLR fa...  \n",
       "10  LRRK2, a gene relevant to Parkinson's disease,...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head(n=3)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of interactions per paper\n",
    "**Note: The number of interactions per paper only takes the filtered interactions extracted from the Intact database**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Figure size 1500x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "\n",
    "data.pubmedId.value_counts().hist (bins=50, figsize=(15,5), color = 'red')\n",
    "plt.title('Papers vs number of interactions distribution')\n",
    "plt.xlabel('Number of interactions per paper')\n",
    "plt.ylabel('Total number of papers')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df = data.pubmedId.value_counts().hist (bins=range(1, 30), figsize=(15,5), color = 'red')\n",
    "\n",
    "plt.title('Papers vs number of interactions distribution ( Filtered distribution of interactions between 1 to 30)')\n",
    "plt.xlabel('Number of interactions per paper')\n",
    "plt.ylabel('Total number of interactions')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Filter out interactions from paper with more than 15 interactions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "metadata": {},
   "outputs": [],
   "source": [
    "pubmed_interaction_count = data.pubmedId.value_counts().to_frame().rename(columns={\"pubmedId\":\"interactionCountPerPubmed\"})\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "interactions_count= pd.DataFrame()\n",
    "data[\"lessThanThreshold\"] = data.apply(lambda r: r[\"pubmedId\"] in  pubmed_interaction_count.query('interactionCountPerPubmed <= 15').index , 1)\n",
    "\n",
    "\n",
    "data.lessThanThreshold.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Has more than 15 interactions')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [],
   "source": [
    "data = data.query(\"lessThanThreshold == 1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of records after filter: 2036\n"
     ]
    }
   ],
   "source": [
    "print(\"Total number of records after filter: {}\".format(data.shape[0]))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Interaction Types distribution"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.interactionType.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Interaction Type Distribution')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionType</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>phosphorylation</th>\n",
       "      <td>1468</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>dephosphorylation</th>\n",
       "      <td>224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>methylation</th>\n",
       "      <td>134</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ubiquitination</th>\n",
       "      <td>75</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>acetylation</th>\n",
       "      <td>70</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>demethylation</th>\n",
       "      <td>37</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>deubiquitination</th>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                   interactionType\n",
       "phosphorylation               1468\n",
       "dephosphorylation              224\n",
       "methylation                    134\n",
       "ubiquitination                  75\n",
       "acetylation                     70\n",
       "demethylation                   37\n",
       "deubiquitination                28"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.interactionType.value_counts().to_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Distinct interaction types per paper"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYgAAAEWCAYAAAB8LwAVAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADl0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uIDMuMC4wLCBodHRwOi8vbWF0cGxvdGxpYi5vcmcvqOYd8AAAIABJREFUeJzt3Xl8XVW5//HPl7FAoGEyQim0QB2QCkoUENSEqhdwALmAYoGC1aJyget0QeUyXPUnyK2KOFbRMlQiF8VWJodCQNQCLfbSSkUKtEAprdBSmjJI2+f+sVbgNL+Tk52kJyfD9/16nVf2XnvvtZ91kpzn7GktRQRmZmYdbVLrAMzMrH9ygjAzs7KcIMzMrCwnCDMzK8sJwszMynKCMDOzspwgBjlJUyV9pUb7lqSfSlop6e6NXPfuktokbbox6y2w37dLeqAv97mxSBov6be1jsMGDieIPiZpkaTlkrYpKfuYpNYahlUthwLvBnaLiLduzIoj4tGIqIuIdRuz3gL7/UNEvLbIupKaJD1e7Zg62fcoSSFps/ayiJgWEe+pRTw2MDlB1MamwFm1DqK7evBtfQ9gUUSsqUY8g13ph/tQ15/fi/4cW285QdTGJcDnJNV3XFDum5+kVkkfy9OnSPqjpG9KekbSw5Lelssfy0cnEzpUu5Ok30laLel2SXuU1P26vGyFpAckHV+ybKqk70u6SdIaoLlMvLtKmpG3Xyjp47l8IvBj4OB8KujCMtteIOnqztqe2/3l3N7Vkn4raadO1h2d27Y6t+c77XWX+yafj+Telac3kXSOpIckPS3pWkk7lPvFdawr1/M5SfdJWiXp55KG5SPEm4Fdc/vb8nvV6b5K2jRR0qPArbn8fyQ9meu/Q9IbSva/laTJkhbn5XdK2gq4I6/yTN73wflv5M6Sbd8m6Z683T2S3layrNJ7P0zS1Tn+Z/K2DZ28X4skfUHS/UqnGn8qaVjJ8vdJmpvr+ZOkN3bY9mxJ9wFrVOaDOL9fZyr9Hzwl6RJJm+Rle0m6Ncf5lKRpKvmfq3Zsg0JE+NWHL2AR8C7gl8BXctnHgNY8PQoIYLOSbVqBj+XpU4C1wKmkI5GvAI8C3wW2BN4DrAbq8vpT8/w78vJLgTvzsm2Ax3JdmwFvAp4C9inZdhVwCOnLxLAy7bkD+B4wDNgf+AdwWEmsd1Z4Ly4Ari6Z36Dtud0PAa8BtsrzF3Wy7p+Bb+Q2viO3+eq8rAl4vNzvIU+fBcwCdsvb/xC4ppOYN6gr13M3sCuwA7AA+ESF/Xa6r5I2XZl/N1vl8o8C2+b1vwXMLanvu/l9GZH/Ht6W19vg/en4+8ixrgROyr/7E/L8jgXe+9OAXwNb530eAGxX4e99PjAy7/OPvPJ3/yZgOXBgrmdCXn/Lkm3n5m236qT+AG7Lde8O/J1X/lf2Jp3i3BLYmfS3+q2+im0wvGoewFB78UqC2Jf04bsz3U8QD5YsG5vXbygpexrYP09PBVpKltUB6/If9oeAP3SI74fA+SXbXlmhLSNzXduWlH0NmFoSa28TxLklyz8F3NJx3fzBsBbYpmTdn1E8QSwAxpUs2wV4qfR3ULJsg7pyPSeWzH8d+EGF/Xa6r5I27VnhPavP6wwnJe3ngf3KrFfu7+jl3wcpMdzdYZs/A6cUeO8/CvwJeGPBv/dPlMwfCTyUp78PfLnD+g8A7yzZ9qNd1B/A4R3inNnJukcDf+mr2AbDa3AeFg0AETFf0g3AOaQPje5YVjL9fK6vY1ldyfxjJfttk7SC9I13D+BASc+UrLsZcFW5bcvYFVgREatLyhYDjUUaUdCTJdPPsWG7SuNYGRte61hMSmBF7AFcL2l9Sdk6oAFY0oMYd+3hvtq9/J4rXff5KnAc6ctE+3Y7kb4ZDyN90++uXUnvUanFpCORdp2991eR3tuWfMrmauBLEfFSJ/sq/RtazCvvzx7ABElnlCzfgg3fv0p/fxXrz6e9LgXeTjoC24R0lNSXsQ1ovgZRW+cDH2fDf8r2D7mtS8pe3cv9vPxBKamOdDj9BOkP/PaIqC951UXEJ0u2rdTd7xPADpK2LSnbnWIfqpDaujHauRTYXiV3huU4yu4nf+juXLL8MeCIDu/DsIgo2o7OlHvviuyrdLuPAEeRjjqHk44MAEQ6HfgCsFfBfZd6gvQhWKrQ7y4iXoqICyNiH9IprfcBJ1fYpDRR7573Dem9+GqH92LriLimG+2oVP//y9uPjYjtgBNJ71tfxjagOUHUUEQsBH4OnFlS9g/SP+mJkjaV9FHKfwB0x5GSDpW0BfBlYFZEPAbcALxG0kmSNs+vt0h6fcH4HyOdavhavnD5RmAi6RtlEXOBdyg90zAc+EK3W5biWAzMBi6UtIWkQ4H3l6zyd2CYpPdK2hw4l/Ttu90PgK8qX7yXtLOko3oSSwfLgB1z23q6r22BF0mnDbcmfegBEBHrgZ8A38gXwDfNF6O3JF0LWg/s2Um9N5F+9x+RtJmkDwH7kP4mKpLULGlsTrTPkk6Rra+wyemSdlO6GP8l0t88wI+AT0g6UMk2+Xe0bedVlfV5SdtLGkm6xtNe/7ZAG7BK0gjg8zWIbUBzgqi9/yJdkCz1cdIf89PAG0gfwr3xM9LRygrSBcUTAfKpofcAHyZ9c3oSuJgNPzy7cgLpW+0TwPWk6xe/L7JhRPyO9A95HzCHAh9OFXyEdEFxBamtV5bsZxXp3PSPScl3DVB6V9OlwAzgt5JWky4iH9iLWNr3+zfgGuDhfCfMrj3Y15WkUx9LgPvz+qU+B8wD7iG1/WJgk4h4jnRq6o953wd1iO1p0jf/z5L+zv4DeF9EPFWgaa8GriMlhwXA7Wx4WrKjnwG/BR4mnQ77So5hNulv/TukUz8LSddJums66e9nLnAjcHkuvxB4M+la342kG0P6OrYBTfmCi9mgIukCYO+IOLHWsQxlkhaRbrAo9KWhB/UHMCYfjXd320VUMbbBwEcQZmZWlhOEmZmV5VNMZmZWlo8gzMysrAH9oNxOO+0Uo0aN6tG2a9asYZttOt48NLi5zUOD2zw09KbNc+bMeSoidu5qvQGdIEaNGsXs2bN7tG1raytNTU0bN6B+zm0eGtzmoaE3bZbU8Sn6snyKyczMynKCMDOzspwgzMysLCcIMzMrywnCzMzKcoIwM7OynCDMzKysqiYISZ+W9FdJ8yVdk8cMGC3pLqUB7n+exyhA0pZ5fmFePqqasZmZWWVVSxB5gI4zgcaI2Jc08PeHSf3VfzMi9ib1sz4xbzKRNGzk3sA383pmZlYj1T7FtBmwlaTNSKNhLQUOIw02AnAFaSBxSMMqXpGnrwPGSeo4POBGM2/JKkadcyOjzrmxWrswMxvQqtqbq6SzSKNaPU8ateks0nCXe+flI4GbI2JfSfOBwyPi8bzsIeDAjiNcSZoETAJoaGg4oKWlpUexLV+ximXPp+mxI4ZXXnmQaGtro66urusVBxG3eWhwm7unubl5TkQ0drVe1fpikrQ96ahgNPAM8D/A4b2tNyKmAFMAGhsbo6d9kVw2bTqT56XmLxrfszoGGvdXMzS4zUNDX7S5mqeY3gU8EhH/iIiXSOPBHgLU51NOALuRxtol/xwJkJcPJ42Va2ZmNVDNBPEocJCkrfO1hHGkQddvA47N60wgDTgOaSD3CXn6WODW8GhGZmY1U7UEERF3kS423wvMy/uaApwNfEbSQmBH4PK8yeXAjrn8M8A51YrNzMy6VtXxICLifOD8DsUPA28ts+4LwHHVjMfMzIrzk9RmZlaWE4SZmZXlBGFmZmU5QZiZWVlOEGZmVpYThJmZleUEYWZmZTlBmJlZWU4QZmZWlhOEmZmV5QRhZmZlOUGYmVlZThBmZlaWE4SZmZVVOEFI2kbSptUMxszM+o9OE4SkTSR9RNKNkpYDfwOWSrpf0iWS9u67MM3MrK9VOoK4DdgL+ALw6ogYGRGvAg4FZgEXSzqxD2I0M7MaqDSi3Lsi4qWOhRGxAvgF8AtJm3e2saTXAj8vKdoTOA+4MpePAhYBx0fEyjxu9aXAkcBzwCkRcW+3WmNmZhtNp0cQHZODpL0l/aukfTpbp8P2D0TE/hGxP3AA6UP/etJY0zMjYgwwk1fGnj4CGJNfk4Dv96xJZma2MVS6BnGbpJ3y9EnATaQP8Z9LOqOb+xkHPBQRi4GjgCty+RXA0Xn6KODKSGYB9ZJ26eZ+zMxsI1FElF8gzY+IffP0PcDhEfG0pK2BWRHxxsI7kX4C3BsR35H0TETU53IBKyOiXtINwEURcWdeNhM4OyJmd6hrEukIg4aGhgNaWlq622YAlq9YxbLn0/TYEcN7VMdA09bWRl1dXa3D6FNu89DgNndPc3PznIho7Gq9StcgXpI0IiKWAG3Amlz+IlD4dldJWwAfIF3s3kBEhKTyGaoTETEFmALQ2NgYTU1N3dn8ZZdNm87kean5i8b3rI6BprW1lZ6+XwOV2zw0uM3VUSlBfBr4raRfAH8FbpX0G9JdTD/txj6OIB09LMvzyyTtEhFL8ymk5bl8CTCyZLvdcpmZmdVApYvUrcDbgKXAS8Ac4AXgjIj4727s4wTgmpL5GcCEPD0BmF5SfrKSg4BVEbG0G/sxM7ONqNIRBBGxil7cTSRpG+DdwGklxRcB10qaCCwGjs/lN5FucV1IuuPp1J7u18zMeq/TBCHp1cD5wHrS8wtnAMeQnqg+q8i3+4hYA+zYoexp0l1NHdcN4PTuBG9mZtVT6UnqqcD9wGOkp6qfB94L/AH4QdUjMzOzmqqUIBoi4rKIuAioj4iLI+KxiLgM2KOP4jMzsxqplCBKl13Zje3MzGwQqPRBP11SHUBEnNtemHtx/Xu1AzMzs9rq9CJ1RJzXSflC4NiqRWRmZv1Cpb6YdpB0nqSP5WcTviTphjwWxPZ9GaSZmfW9SqeYrga2IfXEehvwauBi0t1MU6semZmZ1VSlB+V2jYgjc4d6j0dEUy7/g6S51Q/NzMxqqeJdTPlU0kigTtIoAEk7AltUPzQzM6ulSkcQXyM9NQ3wUeDHuefVfYALqx2YmZnVVqW7mK6RdC1pzIi1kqYD+wNL3Imemdng11VnfetKptcCsyusbmZmg4ifiDYzs7KcIMzMrKwuE4SkvSRtmaebJJ0pqb76oZmZWS0VOYL4BbAu98E0hXTb68+qGpWZmdVckQSxPl+g/iBwWUR8HtilSOWS6iVdJ+lvkhZIOjh34fE7SQ/mn9vndSXp25IWSrpP0pt73iwzM+utIgniJUknkMaPviGXbV6w/kuBWyLidcB+wALgHGBmRIwBZuZ5gCOAMfk1iV4MdWpmZr1XJEGcChwMfDUiHpE0Griqq40kDQfeAVwOEBH/jIhngKOAK/JqVwBH5+mjgCsjmQXUSyp0pGJmZhtfxecgACLifuDMkvlHSJ32dWU08A/gp5L2A+YAZ5FGqmt/0O5JoCFPjyANb9ru8Vzmh/LMzGpAEVF+gXRtRBwvaR7w/60UEW+sWLHUCMwCDomIuyRdCjwLnBER9SXrrYyI7SXdAFwUEXfm8pnA2RExu0O9k0inoGhoaDigpaWlG819xfIVq1j2fJoeO2J4j+oYaNra2qirq6t1GH3KbR4a3ObuaW5unhMRjV2tV+kI4qz88309iiAdATweEXfl+etI1xuWSdolIpbmU0jL8/IlpDuk2u2WyzYQEVNId1PR2NgYTU1NPQrusmnTmTwvNX/R+J7VMdC0trbS0/droHKbhwa3uTo6vQbRfhooIhaXe3VVcUQ8CTwm6bW5aBxwPzCDdMGb/HN6np4BnJzvZjoIWOU+n8zMaqfLaxC9dAYwTdIWwMOkC96bANdKmggsBo7P694EHAksBJ7L65qZWY1UNUFExFyg3HmucWXWDeD0asZjZmbFuS8mMzMrq9MjiM7uXgJE+sJf8S4mMzMb2CqdYurp3UtmZjYIVBpRrss7lczMbPAq0t33QZLukdQm6Z+S1kl6ti+CMzOz2ilykfo7wAnAg8BWwMeA71YzKDMzq71CdzFFxEJg04hYFxE/BQ6vblhmZlZrRZ6DeC4/6DZX0tdJnef59lgzs0GuyAf9SXm9fwPWkPpLOqaaQZmZWe0VSRBHR8QLEfFsRFwYEZ/Bt8CamQ16RRLEhDJlp2zkOMzMrJ+p9CT1CcBHgNGSZpQs2g5YUe3AzMystipdpP4T6YL0TsDkkvLVwH3VDMrMzGqvqyepFwMHS2oA3pIXLYiItX0RnJmZ1U6RJ6mPA+4GjiON3XCXpGOrHZiZmdVWkecgzgXeEhHLASTtDPyeNISomZkNUkXuYtqkPTlkTxfczszMBrAiRxC3SPoNcE2e/xBwc5HKJS0iXdReB6yNiEZJOwA/B0YBi4DjI2KlJAGXkoYdfQ44JSLuLd4UMzPbmLo8EoiIzwM/BN6YX1Mi4j+6sY/miNg/ItqHHj0HmBkRY4CZeR7gCGBMfk0Cvt+NfZiZ2UZW5CL1xRHxy4j4TH5dL+niXuzzKOCKPH0FcHRJ+ZWRzALqJe3Si/2YmVkvKKLcqKIlK0j3RsSbO5TdV2TIUUmPACtJQ5f+MCKmSHomIurzcgErI6Je0g3ARRFxZ142Ezg7ImZ3qHMS6QiDhoaGA1paWoq2dQPLV6xi2fNpeuyI4T2qY6Bpa2ujrq6u1mH0Kbd5aHCbu6e5uXlOyVmdTlV6kvqTwKeAPSWVPhi3LfDHgnEcGhFLJL0K+J2kv5UujIiQVDlDdRARU4ApAI2NjdHU1NSdzV922bTpTJ6Xmr9ofM/qGGhaW1vp6fs1ULnNQ4PbXB2VLlL/jHQx+mu8cp0AYHVEFOpqIyKW5J/LJV0PvBVYJmmXiFiaTyG13yG1hNRTbLvdcpmZmdVApWsQ6yJiUUScEBGLS14vJwdJnR7fSNpG0rbt08B7gPnADF7pAHACMD1PzwBOVnIQsCoilva8aWZm1huVjiCmS5pL+gCfExFrACTtCTSTnqr+EZ0/MNcAXJ8uM7AZ8LOIuEXSPcC1kiaSuvI4Pq9/E+kW14Wk21xP7U3DzMysdyr1xTRO0pHAacAhkrYH1gIPADcCEyLiyQrbPwzsV6b8aWBcmfIATu92C8zMrCoqPigXETeRvtmbmdkQ4y4zzMysLCcIMzMrywnCzMzKKtLVxl6StszTTZLOlFRf/dDMzKyWihxB/AJYJ2lv0hPMI0kP0ZmZ2SBWJEGsz0OMfhC4LPfu6k70zMwGuSIJ4iVJJ5Ceer4hl21evZDMzKw/KJIgTgUOBr4aEY9IGg1cVd2wzMys1io+KCdpU+BLETG+vSwiHgF6Mx6EmZkNABWPICJiHbCHpC36KB4zM+snioxJ/TDwR0kzgDXthRHxjapFZWZmNVckQTyUX5uQBgsyM7MhoMsEEREXAkjaOiKeq35IZmbWHxR5kvpgSfcDf8vz+0n6XtUjMzOzmipym+u3gH8BngaIiP8F3lHNoMzMrPYKddYXEY91KFpXhVjMzKwfKZIgHpP0NiAkbS7pc8CCojuQtKmkv0i6Ic+PlnSXpIWSft5+C62kLfP8wrx8VA/aY2ZmG0mRBPEJ0lCgI4AngP3p3tCgZ7FhQrkY+GZE7A2sBCbm8onAylz+TfwwnplZTXWZICLiqYgYHxENEbFzRJyYx5XukqTdgPcCP87zAg4DrsurXAEcnaePyvPk5ePy+mZmVgOKiMorSHsClwIHAQH8Gfh0RDzcZeXSdcDXSM9PfA44BZiVjxKQNBK4OSL2lTQfODwiHs/LHgIOjIinOtQ5CZgE0NDQcEBLS0vx1pZYvmIVy55P02NHDO9RHQNNW1sbdXV1tQ6jT7nNQ4Pb3D3Nzc1zIqKxq/WKPCj3M+C7pO6+AT4MXAMcWGkjSe8DlkfEHElNBfZTSERMIY1LQWNjYzQ19azqy6ZNZ/K81PxF43tWx0DT2tpKT9+vgcptHhrc5uoocg1i64i4KiLW5tfVwLAC2x0CfEDSIqCFdGrpUqBeUnti2g1YkqeXkAYjIi8fTr611szM+l6RBHGzpHMkjZK0h6T/AG6StIOkHTrbKCK+EBG7RcQo0lHHrblX2NuAY/NqE4DpeXpGnicvvzW6Ov9lZmZVU+QU0/H552kdyj9MuiaxZzf3eTbQIukrwF+Ay3P55cBVkhYCK3L9ZmZWI0X6Yhrd251ERCvQmqcfBt5aZp0XgON6uy8zM9s4ihxBIGlfYB9Krj1ExJXVCsrMzGqvywQh6XygiZQgbgKOAO4EnCDMzAaxIhepjwXGAU9GxKnAfqQ7jMzMbBArkiCej4j1wFpJ2wHLybejmpnZ4FXkGsRsSfXAj4A5QBvpaWozMxvEitzF9Kk8+QNJtwDbRcR91Q3LzMxqrehdTMcAh5Kee7gTcIIwMxvkigw5+j1Sl9/zgPnAaZK+W+3AzMystoocQRwGvL692wtJVwB/rWpUZmZWc0XuYloI7F4yPzKXmZnZIFbkCGJbYIGku0nXIN5KurNpBkBEfKCK8ZmZWY0USRDnVT0KMzPrd4rc5np7XwRiZmb9S5FrEGZmNgQ5QZiZWVmdJghJM/PPi/suHDMz6y8qXYPYRdLbSONKtwAqXRgR91Y1MjMzq6lKCeI84D+B3YBvdFgWpAfoOiVpGHAHsGXez3URcb6k0UALsCOp87+TIuKfkrYkjTFxAPA08KGIWNTtFpmZ2UbR6SmmiLguIo4Avh4RzR1eFZND9iJwWETsB+wPHC7pIOBi4JsRsTewEpiY158IrMzl38zrmZlZjXR5kToivizpA5L+O7/eV6TiSNry7Ob51X7kcV0uvwI4Ok8flefJy8dJ2uC0lpmZ9R3lLpY6X0H6Gunp6Wm56ATgnoj4YpeVS5uSTiPtDXwXuASYlY8SkDQSuDki9pU0Hzg8Ih7Pyx4CDoyIpzrUOQmYBNDQ0HBAS0tL0bZuYPmKVSx7Pk2PHTE0Bshra2ujrq6u1mH0Kbd5aHCbu6e5uXlORDR2tV6RJ6nfC+yfR5Vr76zvL0CXCSIi1gH75wGHrgdeV2B/XdU5BZgC0NjYGE1NTT2q57Jp05k8LzV/0fie1THQtLa20tP3a6Bym4cGt7k6ij4HUV8y3e2v2xHxDHAbcDBQL6k9Me0GLMnTS8hDmeblw0kXq83MrAaKJIivAX+RNDUfPcwBvtrVRpJ2zkcOSNoKeDewgJQojs2rTQCm5+kZeZ68/Nbo6vyXmZlVTZG+mK6R1Aq8JRedHRFPFqh7F+CKfB1iE+DaiLhB0v1Ai6SvkE5VXZ7Xvxy4StJCYAXw4e41xczMNqZCQ45GxFLSN/zC8rjVbypT/jDponfH8heA47qzDzMzqx73xWRmZmU5QZiZWVkVE4SkTSX9ra+CMTOz/qNigsjPMTwgafdK65mZ2eBT5CL19sBf85jUa9oLPRa1mdngViRB/GfVozAzs36n0JjUkvYAxkTE7yVtDWxa/dDMzKyWuryLSdLHSb2r/jAXjQB+Vc2gzMys9orc5no6cAjwLEBEPAi8qppBmZlZ7RVJEC9GxD/bZ3JHeu4jycxskCuSIG6X9EVgK0nvBv4H+HV1wzIzs1orkiDOAf4BzANOA24Czq1mUGZmVntF7mJan7v5vot0aukBd8NtZjb4dZkgJL0X+AHwECBgtKTTIuLmagdnZma1U+RBuclAc0QsBJC0F3Aj4ARhZjaIFbkGsbo9OWQPA6urFI+ZmfUTnSYIScdIOgaYLekmSadImkC6g+meriqWNFLSbZLul/RXSWfl8h0k/U7Sg/nn9rlckr4taaGk+yS9eSO10czMeqDSEcT782sYsAx4J9BEuqNpqwJ1rwU+GxH7AAcBp0vah3RX1MyIGAPMzPMARwBj8msS8P3uNsbMzDaeTq9BRMSpvak4D1O6NE+vlrSA1E3HUaREA3AF0AqcncuvzHdIzZJUL2mXXI+ZmfUxdXXHqqTRwBnAKEoSSne6+5Y0CrgD2Bd4NCLqc7mAlRFRL+kG4KKIuDMvmwmcHRGzO9Q1iXSEQUNDwwEtLS1Fw9jA8hWrWPZ8mh47YniP6hho2traqKurq3UYfcptHhrc5u5pbm6eExGNXa1X5C6mXwGXk649rO9uIJLqgF8A/x4Rz6ackERESOrWMxURMQWYAtDY2BhNTU3dDQmAy6ZNZ/K81PxF43tWx0DT2tpKT9+vgcptHhrc5uookiBeiIhv96RySZuTksO0iPhlLl7WfupI0i7A8ly+BBhZsvluuczMzGqgyG2ul0o6X9LBkt7c/upqo3z66HJgQUR8o2TRDGBCnp4ATC8pPznfzXQQsMrXH8zMaqfIEcRY4CTgMF45xRR5vpJD8nbzJM3NZV8ELgKulTQRWAwcn5fdBBwJLASeA3p1kdzMzHqnSII4DtiztMvvIvLFZnWyeFyZ9YM09oSZmfUDRU4xzQfqqx2ImZn1L0WOIOqBv0m6B3ixvbA7t7mamdnAUyRBnF/1KMzMrN8pMh7E7X0RiJmZ9S9FxoNYzStjUG8BbA6siYjtqhmYmZnVVpEjiG3bp/OzDUeROt8zM7NBrMhdTC+L5FfAv1QpHjMz6yeKnGI6pmR2E6AReKFqEZmZWb9Q5C6m95dMrwUWkU4zmZnZIFbkGoS7vDAzG4I6TRCSzquwXUTEl6sQj5mZ9ROVjiDWlCnbBpgI7Ag4QZiZDWKVhhyd3D4taVvgLFIPqy3A5M62MzOzwaHiNQhJOwCfAcaTxo9+c0Ss7IvAzMystipdg7gEOIY0vOfYiGjrs6jMzKzmKj0o91lgV+Bc4AlJz+bXaknP9k14ZmZWK5WuQXTrKWszMxtcqpYEJP1E0nJJ80vKdpD0O0kP5p/b53JJ+rakhZLuKzLmtZmZVVc1jxKmAod3KDsHmBkRY4CZeR7gCGBMfk0Cvl/FuMzMrICqJYiIuANY0aH4KNLdUOSfR5eUX5k7A5wF1EvapVqxmZlZ1xQRXa/V08qlUcANEbFvnn8mIurztICVEVEv6Qbgooi4My+bCZwdEbPL1DmJdJRBQ0PDAS0tLT2KbfmKVSx7Pk2PHTG8R3UMNG1tbdTV1dU6jD7lNg8NbnP3NDc3z4mIxq7WK9JZX1VEREjqdnaKiCmkW29pbGwoDV9QAAAJeUlEQVSMpqamHu3/smnTmTwvNX/R+J7VMdC0trbS0/droHKbhwa3uTr6+k6lZe2njvLP5bl8CTCyZL3dcpmZmdVIXyeIGcCEPD0BmF5SfnK+m+kgYFVELO3j2MzMrETVTjFJugZoAnaS9DhwPnARcK2kicBi4Pi8+k3AkcBC4DlSn09mZlZDVUsQEXFCJ4vGlVk3gNOrFYuZmXWfn5Y2M7OynCDMzKwsJwgzMyvLCcLMzMpygjAzs7KcIMzMrCwnCDMzK8sJwszMynKCMDOzspwgzMysLCcIMzMrywnCzMzKqtmAQWZm1j2jzrnx5emph29T9f35CMLMzMpygjAzs7KcIMzMrCwnCDMzK6tfJQhJh0t6QNJCSefUOh4zs6Gs3yQISZsC3wWOAPYBTpC0T22jMjMbuvpNggDeCiyMiIcj4p9AC3BUjWMyMxuy+tNzECOAx0rmHwcO7LiSpEnApDzbJumBHu5vJ+ApAF3cwxoGnpfbPIS4zUPDkGtz88W9avMeRVbqTwmikIiYAkzpbT2SZkdE40YIacBwm4cGt3lo6Is296dTTEuAkSXzu+UyMzOrgf6UIO4BxkgaLWkL4MPAjBrHZGY2ZPWbU0wRsVbSvwG/ATYFfhIRf63iLnt9mmoAcpuHBrd5aKh6mxUR1d6HmZkNQP3pFJOZmfUjThBmZlbWoE4Qkn4iabmk+Z0sl6Rv56497pP05r6OcWMr0Obxua3zJP1J0n59HePG1lWbS9Z7i6S1ko7tq9iqpUibJTVJmivpr5Ju78v4qqHA3/ZwSb+W9L+5zaf2dYwbk6SRkm6TdH9uz1ll1qnqZ9igThDAVODwCsuPAMbk1yTg+30QU7VNpXKbHwHeGRFjgS8zOC7uTaVym9u7crkY+G1fBNQHplKhzZLqge8BH4iINwDH9VFc1TSVyr/n04H7I2I/oAmYnO+IHKjWAp+NiH2Ag4DTy3Q/VNXPsEGdICLiDmBFhVWOAq6MZBZQL2mXvomuOrpqc0T8KSJW5tlZpOdNBrQCv2eAM4BfAMurH1H1FWjzR4BfRsSjef0B3+4CbQ5gW0kC6vK6a/sitmqIiKURcW+eXg0sIPU4Uaqqn2GDOkEUUK57j46/gMFsInBzrYOoNkkjgA8yOI4Qi3oNsL2kVklzJJ1c64D6wHeA1wNPAPOAsyJifW1D2jgkjQLeBNzVYVFVP8P6zXMQ1rckNZMSxKG1jqUPfAs4OyLWpy+XQ8JmwAHAOGAr4M+SZkXE32sbVlX9CzAXOAzYC/idpD9ExLO1Dat3JNWRjn7/va/bMtQTxJDs3kPSG4EfA0dExNO1jqcPNAItOTnsBBwpaW1E/Kq2YVXV48DTEbEGWCPpDmA/YDAniFOBiyI93LVQ0iPA64C7axtWz0nanJQcpkXEL8usUtXPsKF+imkGcHK+E+AgYFVELK11UNUkaXfgl8BJg/zb5MsiYnREjIqIUcB1wKcGeXIAmA4cKmkzSVuTekZeUOOYqu1R0hETkhqA1wIP1zSiXsjXUi4HFkTENzpZraqfYYP6CELSNaS7GXaS9DhwPrA5QET8ALgJOBJYCDxH+gYyoBVo83nAjsD38jfqtQO9F8wCbR50umpzRCyQdAtwH7Ae+HFEVLwNuL8r8Hv+MjBV0jxApNOKA7kL8EOAk4B5kubmsi8Cu0PffIa5qw0zMytrqJ9iMjOzTjhBmJlZWU4QZmZWlhOEmZmV5QRhZmZlOUFYTUgKSZNL5j8n6YKNVPfUvuixVdJxkhZIuq1D+a6Sriuw/RerF93L+xgl6SMl842Svl3t/drg4ARhtfIicIyknWodSClJ3Xk2aCLw8YhoLi2MiCciokiC6naCyL3SdscoUsd9AETE7Ig4s7v7taHJCcJqZS2pq/FPd1zQ8QhAUlv+2STpdknTJT0s6aI8vsXdeXyLvUqqeZek2ZL+Lul9eftNJV0i6Z7cd/5pJfX+QdIM4P4y8ZyQ658v6eJcdh6pH6vLJV3SYf1R7WMWSDpF0i8l3SLpQUlfz+UXAVspjdcwLZedmNsyV9IP25OBpDZJkyX9L3CwpPNyG+ZLmpKfuEXS3pJ+rzQewr35/bgIeHuu89O5rTfk9XeQ9Kv8XszKXbAg6QKlsRda8/t8Zi7fRtKNuf75kj7UnV+4DUAR4Zdfff4C2oDtgEXAcOBzwAV52VTg2NJ1888m4BlgF2BLUp8zF+ZlZwHfKtn+FtIXoDGkfomGkfrLPzevsyUwGxid610DjC4T566kLhx2JvU8cCtwdF7WCjSW2WYUMD9Pn0Lq7mF4jmExMLK0XXn69cCvgc3z/PeAk/N0AMeXrLtDyfRVwPvz9F3AB/P0MGDr3LYbStZ/eR64DDg/Tx8GzM3TFwB/yu/RTsDTpCeW/xX4UUldw2v9d+RXdV8+grCaidQz5ZVAd0553BOpn/wXgYd4ZQCgeaQP5nbXRsT6iHiQ9AH9OuA9pH5r5pI+THckJRCAuyPikTL7ewvQGhH/iIi1wDTgHd2IF2BmRKyKiBdIRyh7lFlnHKn31XtyfOOAPfOydaQO29o1S7ordylxGPAGSdsCIyLieoCIeCEinusirkNJCYaIuBXYUdJ2edmNEfFipK4qlgMNpPf43ZIulvT2iFjVrXfBBpxB3ReTDQjfAu4FflpStpZ8+lPSJkDpqGAvlkyvL5lfz4Z/zx37kAlS/zxnRMRvShdIaiIdQVRLaczrKP9/J+CKiPhCmWUvRMQ6AEnDSEcXjRHxWL6wP2wjxwtlYo6IvysNaXkk8BVJMyPiv6qwb+snfARhNRURK4BrSRd82y0ifZsG+AC5Q7ZuOk7SJvk8/J7AA8BvgE8qdaGMpNdI2qaLeu4G3ilpp3xN4ARgY43v/FJ7LMBM4FhJr8qx7SCp3JFGezJ4SmmcgGPh5RHHHpd0dN5+S6VeXFcD23ay/z8A4/P6TcBTUWG8AUm7As9FxNXAJcCAH8PdKvMRhPUHk4F/K5n/ETA9X5S9hZ59u3+U9OG+HfCJiHhB0o9Jp6HuzRd2/wEcXamSiFgq6RzgNtK3/BsjYnoP4ilnCnCfpHsjYrykc4Hf5qOml0hjLC/uEM8zkn4EzAeeBO4pWXwS8ENJ/5W3P47Um+u6/F5OBf5Ssv4FwE8k3UfqCXRCF/GOBS6RtD7X/8nuN9kGEvfmamZmZfkUk5mZleUEYWZmZTlBmJlZWU4QZmZWlhOEmZmV5QRhZmZlOUGYmVlZ/wdBfHRqq7krkQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "distinct_no_papers = data['pubmedId'].nunique()\n",
    "data.groupby('pubmedId')['interactionType'].nunique().hist(bins=100)\n",
    "plt.title(\"Number of unique interactions per paper\")\n",
    "plt.xlabel('Number of interactions')\n",
    "plt.ylabel('Number of papers (total is {})'.format(distinct_no_papers))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Postive vs Negative Relationships"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.isNegative.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Is Negtive relationship')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Number of participants per interaction"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data[\"participants\"].apply(lambda x: len(x)).hist (bins=50, figsize=(5,5), color = 'green')\n",
    "plt.title(\"Participants count per interaction\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Explore if the abstract contains the trigger word"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "data[\"hasTriggerWord\"] = data.apply(lambda r: r[\"interactionType\"].lower() in r[\"pubmedabstract\"].lower() , 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 360x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data.hasTriggerWord.value_counts().plot.pie(autopct='%.2f',figsize=(5, 5))\n",
    "plt.title('Has trigger word')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 3240x2160 with 7 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig, ax = plt.subplots( 7,1, figsize=(45,30))\n",
    "data.groupby(['hasTriggerWord', 'interactionType']).size().unstack().plot(kind='pie', subplots='True',autopct='%.2f', ax=ax)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Explore how many of the entity alias are mentioned in the abstract"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 15.2 s, sys: 67.2 ms, total: 15.3 s\n",
      "Wall time: 15.4 s\n"
     ]
    }
   ],
   "source": [
    "%%time \n",
    "\n",
    "from difflib import SequenceMatcher\n",
    "def getEntityMentionsCount(r):\n",
    "    count = 0\n",
    "    abstract = r[\"pubmedabstract\"].lower()\n",
    "    abstract_len= len(abstract)\n",
    "    for p in r[\"participants\"]:\n",
    "        if p is None or p['alias'] is None : continue\n",
    "        \n",
    "        for a in p['alias']:\n",
    "            alias = a[0].lower()\n",
    "            s = SequenceMatcher(None, abstract, alias)\n",
    "            _,_,match_size = s.find_longest_match(0, len(abstract), 0, len(alias))\n",
    "            if match_size >= 3 and match_size >= len(alias)/2 :\n",
    "                count += 1\n",
    "        \n",
    "    return count\n",
    "        \n",
    "\n",
    "data[\"entityMentionsCount\"] = data.apply(lambda r: getEntityMentionsCount(r)  , 1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "data['entityMentionsCount'].hist ( bins=150, figsize=(15,5), color = 'red')\n",
    "plt.title('Entity mentions count distribution')\n",
    "plt.xlabel('Entity name mentions count in abstract')\n",
    "plt.ylabel('Total number of interactions')\n",
    "\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "(data['entityMentionsCount'] > 0).value_counts().plot.pie(autopct='%.2f')\n",
    "plt.title(\"Percentage of interactions with entity mentions \")\n",
    "plt.ylabel(\"Entity mentions > 0\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Randomly eye ball interactions with no entity mentions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedabstract</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2214</th>\n",
       "      <td>[{'uniprotid': 'Q5TCN2', 'alias': [['sgk1_human'], ['Serine/threonine-protein kinase Sgk1'], ['SGK1'], ['SGK'], ['Serum/glucocorticoid-regulated kinase 1']]}, {'uniprotid': 'Q6FI20', 'alias': [['pdpk1_human'], ['3-phosphoinositide-dependent protein kinase 1'], ['PDPK1'], ['PDK1']]}]</td>\n",
       "      <td>NM23-H1 is a member of the NM23/NDP kinase gene family and a putative metastasis suppressor. Previously, a screen for NM23-H1-interacting proteins that could potentially modulate its activity identified serine-threonine kinase receptor-associated protein (STRAP), a transforming growth factor (TGF)-beta receptor-interacting protein. Through the use of cysteine to serine amino acid substitution mutants of NM23-H1 (C4S, C109S, and C145S) and STRAP (C152S, C270S, and C152S/C270S), we demonstrated that the association between these two proteins is dependent on Cys(145) of NM23-H1 and Cys(152) and Cys(270) of STRAP but did not appear to involve Cys(4) and Cys(109) of NM23-H1, suggesting that a disulfide linkage involving Cys(145) of NM23-H1 and Cys(152) or Cys(270) of STRAP mediates complex formation. The interaction was dependent on the presence of dithiothreitol or beta-mercaptoethanol but not H(2)O(2). Ectopic expression of wild-type NM23-H1, but not NM23-H1(C145S), negatively regulated TGF-beta signaling in a dose-dependent manner, enhanced stable association between the TGF-beta receptor and Smad7, and prevented nuclear translocation of Smad3. Similarly, wild-type NM23-H1 inhibited TGF-beta-induced apoptosis and growth inhibition, whereas NM23-H1(C145S) had no effect. Knockdown of NM23-H1 by small interfering RNA stimulated TGF-beta signaling. Coexpression of wild-type STRAP, but not STRAP(C152S/C270S), significantly stimulated NM23-H1-induced growth of HaCaT cells. These results suggest that the direct interaction of NM23-H1 and STRAP is important for the regulation of TGF-beta-dependent biological activity as well as NM23-H1 activity.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1071</th>\n",
       "      <td>[{'uniprotid': 'Q5TI68', 'alias': [['ks6a2_human'], ['Ribosomal protein S6 kinase alpha-2'], ['RPS6KA2'], ['RSK3'], ['90 kDa ribosomal protein S6 kinase 2'], ['MAPKAPK1C'], ['Ribosomal S6 kinase 3'], ['pp90RSK3'], ['MAP kinase-activated protein kinase 1c']]}, {'uniprotid': 'Q4VBY7', 'alias': [['rs6_human'], ['40S ribosomal protein S6'], ['RPS6'], ['Phosphoprotein NP33'], ['Small ribosomal subunit protein eS6'], ['OK/SW-cl.2']]}]</td>\n",
       "      <td>Patients with small cell lung cancer (SCLC) die because of chemoresistance. Fibroblast growth factor-2 (FGF-2) increases the expression of antiapoptotic proteins, XIAP and Bcl-X(L), and triggers chemoresistance in SCLC cells. Here we show that these effects are mediated through the formation of a specific multiprotein complex comprising B-Raf, PKCepsilon and S6K2. S6K1, Raf-1 and other PKC isoforms do not form similar complexes. RNAi-mediated downregulation of B-Raf, PKCepsilon or S6K2 abolishes FGF-2-mediated survival. In contrast, overexpression of PKCepsilon increases XIAP and Bcl-X(L) levels and chemoresistance in SCLC cells. In a tetracycline-inducible system, increased S6K2 kinase activity triggers upregulation of XIAP, Bcl-X(L) and prosurvival effects. However, increased S6K1 kinase activity has no such effect. Thus, S6K2 but not S6K1 mediates prosurvival/chemoresistance signalling.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>963</th>\n",
       "      <td>[{'uniprotid': 'P49674', 'alias': [['kc1e_human'], ['Casein kinase I isoform epsilon'], ['CSNK1E']]}, {'uniprotid': 'Q15162', 'alias': [['apc_human'], ['Adenomatous polyposis coli protein'], ['APC'], ['DP2.5'], ['Deleted in polyposis 2.5']]}]</td>\n",
       "      <td>Although casein kinase Iepsilon (CKIepsilon) has been shown to regulate the Wnt signaling pathway positively, its mode of action is not clear. In this study we show that CKIepsilon activates the Wnt signaling pathway in co-operation with Dvl. CKIepsilon and Axin associated with different sites of Dvl, and CKIepsilon and Dvl interacted with distinct regions on Axin. Therefore, these three proteins formed a ternary complex. Either low expression of Dvl or CKIepsilon alone did not accumulate beta-catenin, but their co-expression accumulated greatly. Dvl and CKIepsilon activated the transcriptional activity of T cell factor (Tcf) synergistically. Although the Dvl mutant that binds to Axin but not to CKIepsilon activated Tcf, it did not synergize with CKIepsilon. Another Dvl mutant that does not bind to Axin did not activate Tcf irrespective of the presence of CKIepsilon. Furthermore, Dvl and CKIepsilon co-operatively induced axis duplication of Xenopus embryos. These results indicate that Dvl and CKIepsilon synergistically activated the Wnt signaling pathway and that the binding of the complex of Dvl and CKIepsilon to Axin is necessary for their synergistic action.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2228</th>\n",
       "      <td>[{'uniprotid': 'B1AMQ6', 'alias': [['melk_human'], ['Maternal embryonic leucine zipper kinase'], ['Protein kinase PK38'], ['MELK'], ['KIAA0175'], ['Protein kinase Eg3'], ['Tyrosine-protein kinase MELK']]}, {'uniprotid': 'Q9BZR7', 'alias': [['b2l14_human'], ['Apoptosis facilitator Bcl-2-like protein 14'], ['Apoptosis regulator Bcl-G'], ['BCL2L14'], ['BCLG']]}]</td>\n",
       "      <td>Cancer therapies directed at specific molecular targets in signaling pathways of cancer cells, such as tamoxifen, aromatase inhibitors and trastuzumab, have proven useful for treatment of advanced breast cancers. However, increased risk of endometrial cancer with long-term tamoxifen administration and of bone fracture due to osteoporosis in postmenopausal women undergoing aromatase inhibitor therapy are recognized side effects. These side effects as well as drug resistance make it necessary to search for novel molecular targets for drugs on the basis of well-characterized mechanisms of action.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3171</th>\n",
       "      <td>[{'uniprotid': 'A8WCQ2', 'alias': [['casa1_bovin'], ['Alpha-S1-casein'], ['CSN1S1']]}, {'uniprotid': 'Q6NZX8', 'alias': [['nek2_human'], ['Serine/threonine-protein kinase Nek2'], ['NimA-like protein kinase 1'], ['HSPK 21'], ['NEK2'], ['NLK1'], ['Never in mitosis A-related kinase 2'], ['NEK2A']]}]</td>\n",
       "      <td>Fidelity of chromosome segregation is ensured by a tension-dependent error correction system that prevents stabilization of incorrect chromosome-microtubule attachments. Unattached or incorrectly attached chromosomes also activate the spindle assembly checkpoint, thus delaying mitotic exit until all chromosomes are bioriented. The Aurora B kinase is widely recognized as a component of error correction. Conversely, its role in the checkpoint is controversial. Here, we report an analysis of the role of Aurora B in the spindle checkpoint under conditions believed to uncouple the effects of Aurora B inhibition on the checkpoint from those on error correction. Partial inhibition of several checkpoint and kinetochore components, including Mps1 and Ndc80, strongly synergizes with inhibition of Aurora B activity and dramatically affects the ability of cells to arrest in mitosis in the presence of spindle poisons. Thus, Aurora B might contribute to spindle checkpoint signalling independently of error correction. Our results support a model in which Aurora B is at the apex of a signalling pyramid whose sensory apparatus promotes the concomitant activation of error correction and checkpoint signalling pathways.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>282</th>\n",
       "      <td>[{'uniprotid': 'B2RCR8', 'alias': [['stk4_human'], ['Serine/threonine-protein kinase 4'], ['STK4'], ['MST1'], ['STE20-like kinase MST1'], ['Mammalian STE20-like protein kinase 1'], ['Serine/threonine-protein kinase Krs-2'], ['KRS2']]}]</td>\n",
       "      <td>The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1683</th>\n",
       "      <td>[{'uniprotid': 'Q5VYA9', 'alias': [['zic2_human'], ['Zinc finger protein ZIC 2'], ['ZIC2'], ['Zinc finger protein of the cerebellum 2']]}, {'uniprotid': 'Q9UME3', 'alias': [['prkdc_human'], ['DNA-dependent protein kinase catalytic subunit'], ['PRKDC'], ['HYRC'], ['HYRC1'], ['DNPK1'], ['p460']]}]</td>\n",
       "      <td>Signal transducers and activators of transcription (STATs) play a pleomorphic role in signal transduction, similarly to an oncogene. Suppressors of cytokine signaling (SOCS) inhibit STAT pathways. In breast cancer, little is known about the correlation among STATs, SOCS, and clinicopathological/biological features. Therefore, we investigated p-STAT3 (activated form of STAT3) and SOCS-1/3 expression, and clarified their correlation. Immunohistochemical staining for p-STAT3 antigen was performed in 74 surgically resected primary breast cancers. Real-time RT-PCR was used to measure mRNA expression of SOCS-1 and SOCS-3. There were no significant correlations between p-STAT3 expression and clinicopathological/biological features. SOCS-3 mRNA expression in the lymph node-positive group was significantly lower than that in the negative group (p=0.013). Among three groups divided based on the number of involved lymph nodes (node-negative group, 1-3 involved nodes group, 4 or more involved nodes group), the group with 4 or more involved nodes had the lowest expression of SOCS-3 (p=0.043). Correlations were not seen between SOCS-1 and SOCS-3 expression and other clinicopathological/biological features, except for blood vessel invasion. There were no statistical correlations between either SOCS-1 or SOCS-3 mRNA expression and p-STAT3 expression. Reduced expression of SOCS-3 is closely related to lymph node metastasis. Therefore, SOCS-3 may be a good predictor for lymph node metastasis.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3361</th>\n",
       "      <td>[{'uniprotid': 'P02305', 'alias': [['h4_human'], ['Histone H4'], ['HIST1H4A'], ['H4/A'], ['H4FA'], ['HIST1H4B'], ['H4/I'], ['H4FI'], ['HIST1H4C'], ['H4/G'], ['H4FG'], ['HIST1H4D'], ['H4/B'], ['H4FB'], ['HIST4H4'], ['HIST1H4E'], ['H4/J'], ['H4FJ'], ['HIST1H4F'], ['H4/C'], ['H4FC'], ['HIST1H4H'], ['H4/H'], ['H4FH'], ['HIST1H4I'], ['H4/M'], ['H4FM'], ['HIST1H4J'], ['H4/E'], ['H4FE'], ['HIST1H4K'], ['H4/D'], ['H4FD'], ['HIST1H4L'], ['H4/K'], ['H4FK'], ['HIST2H4A'], ['H4/N'], ['H4F2'], ['H4FN'], ['HIST2H4'], ['HIST2H4B'], ['H4/O'], ['H4FO']]}, {'uniprotid': 'Q9NZ06', 'alias': [['anm1_human'], ['Protein arginine N-methyltransferase 1'], ['PRMT1'], ['Interferon receptor 1-bound protein 4'], ['Histone-arginine N-methyltransferase PRMT1'], ['HMT2'], ['HRMT1L2'], ['IR1B4']]}]</td>\n",
       "      <td>Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochemical functions. The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization. Here we describe a proteomics method to profile quantitatively the intrinsic reactivity of cysteine residues en masse directly in native biological systems. Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification. Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulphur protein biogenesis. We also demonstrate that quantitative reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>465</th>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}]</td>\n",
       "      <td>During interphase in Drosophila neuroblasts, the Centrobin (CNB)-positive daughter centriole retains pericentriolar material (PCM) and organizes an aster that is a key determinant of the orientation of cell division. Here we show that daughter centrioles depleted of CNB cannot fulfil this function whereas mother centrioles that carry ectopic CNB can. CNB co-precipitates with a set of centrosomal proteins that include -TUB, ANA2, CNN, SAS-4, ASL, DGRIP71, POLO and SAS-6. Following chemical inhibition of POLO or removal of three POLO phosphorylation sites present in CNB, the interphase microtubule aster is lost. These results demonstrate that centriolar CNB localization is both necessary and sufficient to enable centrioles to retain PCM and organize the interphase aster in Drosophila neuroblasts. They also reveal an interphase function for POLO in this process that seems to have co-opted part of the protein network involved in mitotic centrosome maturation.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>[{'uniprotid': 'Q9H2Y1', 'alias': [['hipk2_human'], ['Homeodomain-interacting protein kinase 2'], ['HIPK2']]}]</td>\n",
       "      <td>The function of many protein kinases is controlled by the phosphorylation of a critical tyrosine residue in the activation loop. Dual specificity tyrosine-phosphorylation-regulated kinases (DYRKs) autophosphorylate on this tyrosine residue but phosphorylate substrates on aliphatic amino acids. This study addresses the mechanism of dual specificity kinase activity in DYRK1A and related kinases. Tyrosine autophosphorylation of DYRK1A occurred rapidly during in vitro translation and did not depend on the non-catalytic domains or other proteins. Expression in bacteria as well as in mammalian cells revealed that tyrosine kinase activity of DYRK1A is not restricted to the co-translational autophosphorylation in the activation loop. Moreover, mature DYRK1A was still capable of tyrosine autophosphorylation. Point mutants of DYRK1A and DYRK2 lacking the activation loop tyrosine showed enhanced tyrosine kinase activity. A series of structurally diverse DYRK1A inhibitors was used to pharmacologically distinguish different conformational states of the catalytic domain that are hypothesized to account for the dual specificity kinase activity. All tested compounds inhibited substrate phosphorylation with higher potency than autophosphorylation but none of the tested inhibitors differentially inhibited threonine and tyrosine kinase activity. Finally, the related cyclin-dependent kinase-like kinases (CLKs), which lack the activation loop tyrosine, autophosphorylated on tyrosine both in vitro and in living cells. We propose a model of DYRK autoactivation in which tyrosine autophosphorylation in the activation loop stabilizes a conformation of the catalytic domain with enhanced serine/threonine kinase activity without disabling tyrosine phosphorylation. The mechanism of dual specificity kinase activity probably applies to related serine/threonine kinases that depend on tyrosine autophosphorylation for maturation.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  participants  \\\n",
       "2214                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               [{'uniprotid': 'Q5TCN2', 'alias': [['sgk1_human'], ['Serine/threonine-protein kinase Sgk1'], ['SGK1'], ['SGK'], ['Serum/glucocorticoid-regulated kinase 1']]}, {'uniprotid': 'Q6FI20', 'alias': [['pdpk1_human'], ['3-phosphoinositide-dependent protein kinase 1'], ['PDPK1'], ['PDK1']]}]   \n",
       "1071                                                                                                                                                                                                                                                                                                                                                          [{'uniprotid': 'Q5TI68', 'alias': [['ks6a2_human'], ['Ribosomal protein S6 kinase alpha-2'], ['RPS6KA2'], ['RSK3'], ['90 kDa ribosomal protein S6 kinase 2'], ['MAPKAPK1C'], ['Ribosomal S6 kinase 3'], ['pp90RSK3'], ['MAP kinase-activated protein kinase 1c']]}, {'uniprotid': 'Q4VBY7', 'alias': [['rs6_human'], ['40S ribosomal protein S6'], ['RPS6'], ['Phosphoprotein NP33'], ['Small ribosomal subunit protein eS6'], ['OK/SW-cl.2']]}]   \n",
       "963                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         [{'uniprotid': 'P49674', 'alias': [['kc1e_human'], ['Casein kinase I isoform epsilon'], ['CSNK1E']]}, {'uniprotid': 'Q15162', 'alias': [['apc_human'], ['Adenomatous polyposis coli protein'], ['APC'], ['DP2.5'], ['Deleted in polyposis 2.5']]}]   \n",
       "2228                                                                                                                                                                                                                                                                                                                                                                                                                                 [{'uniprotid': 'B1AMQ6', 'alias': [['melk_human'], ['Maternal embryonic leucine zipper kinase'], ['Protein kinase PK38'], ['MELK'], ['KIAA0175'], ['Protein kinase Eg3'], ['Tyrosine-protein kinase MELK']]}, {'uniprotid': 'Q9BZR7', 'alias': [['b2l14_human'], ['Apoptosis facilitator Bcl-2-like protein 14'], ['Apoptosis regulator Bcl-G'], ['BCL2L14'], ['BCLG']]}]   \n",
       "3171                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 [{'uniprotid': 'A8WCQ2', 'alias': [['casa1_bovin'], ['Alpha-S1-casein'], ['CSN1S1']]}, {'uniprotid': 'Q6NZX8', 'alias': [['nek2_human'], ['Serine/threonine-protein kinase Nek2'], ['NimA-like protein kinase 1'], ['HSPK 21'], ['NEK2'], ['NLK1'], ['Never in mitosis A-related kinase 2'], ['NEK2A']]}]   \n",
       "282                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                [{'uniprotid': 'B2RCR8', 'alias': [['stk4_human'], ['Serine/threonine-protein kinase 4'], ['STK4'], ['MST1'], ['STE20-like kinase MST1'], ['Mammalian STE20-like protein kinase 1'], ['Serine/threonine-protein kinase Krs-2'], ['KRS2']]}]   \n",
       "1683                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  [{'uniprotid': 'Q5VYA9', 'alias': [['zic2_human'], ['Zinc finger protein ZIC 2'], ['ZIC2'], ['Zinc finger protein of the cerebellum 2']]}, {'uniprotid': 'Q9UME3', 'alias': [['prkdc_human'], ['DNA-dependent protein kinase catalytic subunit'], ['PRKDC'], ['HYRC'], ['HYRC1'], ['DNPK1'], ['p460']]}]   \n",
       "3361  [{'uniprotid': 'P02305', 'alias': [['h4_human'], ['Histone H4'], ['HIST1H4A'], ['H4/A'], ['H4FA'], ['HIST1H4B'], ['H4/I'], ['H4FI'], ['HIST1H4C'], ['H4/G'], ['H4FG'], ['HIST1H4D'], ['H4/B'], ['H4FB'], ['HIST4H4'], ['HIST1H4E'], ['H4/J'], ['H4FJ'], ['HIST1H4F'], ['H4/C'], ['H4FC'], ['HIST1H4H'], ['H4/H'], ['H4FH'], ['HIST1H4I'], ['H4/M'], ['H4FM'], ['HIST1H4J'], ['H4/E'], ['H4FE'], ['HIST1H4K'], ['H4/D'], ['H4FD'], ['HIST1H4L'], ['H4/K'], ['H4FK'], ['HIST2H4A'], ['H4/N'], ['H4F2'], ['H4FN'], ['HIST2H4'], ['HIST2H4B'], ['H4/O'], ['H4FO']]}, {'uniprotid': 'Q9NZ06', 'alias': [['anm1_human'], ['Protein arginine N-methyltransferase 1'], ['PRMT1'], ['Interferon receptor 1-bound protein 4'], ['Histone-arginine N-methyltransferase PRMT1'], ['HMT2'], ['HRMT1L2'], ['IR1B4']]}]   \n",
       "465                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}]   \n",
       "158                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             [{'uniprotid': 'Q9H2Y1', 'alias': [['hipk2_human'], ['Homeodomain-interacting protein kinase 2'], ['HIPK2']]}]   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                pubmedabstract  \n",
       "2214                                                                                                                                                                                                                                                                           NM23-H1 is a member of the NM23/NDP kinase gene family and a putative metastasis suppressor. Previously, a screen for NM23-H1-interacting proteins that could potentially modulate its activity identified serine-threonine kinase receptor-associated protein (STRAP), a transforming growth factor (TGF)-beta receptor-interacting protein. Through the use of cysteine to serine amino acid substitution mutants of NM23-H1 (C4S, C109S, and C145S) and STRAP (C152S, C270S, and C152S/C270S), we demonstrated that the association between these two proteins is dependent on Cys(145) of NM23-H1 and Cys(152) and Cys(270) of STRAP but did not appear to involve Cys(4) and Cys(109) of NM23-H1, suggesting that a disulfide linkage involving Cys(145) of NM23-H1 and Cys(152) or Cys(270) of STRAP mediates complex formation. The interaction was dependent on the presence of dithiothreitol or beta-mercaptoethanol but not H(2)O(2). Ectopic expression of wild-type NM23-H1, but not NM23-H1(C145S), negatively regulated TGF-beta signaling in a dose-dependent manner, enhanced stable association between the TGF-beta receptor and Smad7, and prevented nuclear translocation of Smad3. Similarly, wild-type NM23-H1 inhibited TGF-beta-induced apoptosis and growth inhibition, whereas NM23-H1(C145S) had no effect. Knockdown of NM23-H1 by small interfering RNA stimulated TGF-beta signaling. Coexpression of wild-type STRAP, but not STRAP(C152S/C270S), significantly stimulated NM23-H1-induced growth of HaCaT cells. These results suggest that the direct interaction of NM23-H1 and STRAP is important for the regulation of TGF-beta-dependent biological activity as well as NM23-H1 activity.  \n",
       "1071                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Patients with small cell lung cancer (SCLC) die because of chemoresistance. Fibroblast growth factor-2 (FGF-2) increases the expression of antiapoptotic proteins, XIAP and Bcl-X(L), and triggers chemoresistance in SCLC cells. Here we show that these effects are mediated through the formation of a specific multiprotein complex comprising B-Raf, PKCepsilon and S6K2. S6K1, Raf-1 and other PKC isoforms do not form similar complexes. RNAi-mediated downregulation of B-Raf, PKCepsilon or S6K2 abolishes FGF-2-mediated survival. In contrast, overexpression of PKCepsilon increases XIAP and Bcl-X(L) levels and chemoresistance in SCLC cells. In a tetracycline-inducible system, increased S6K2 kinase activity triggers upregulation of XIAP, Bcl-X(L) and prosurvival effects. However, increased S6K1 kinase activity has no such effect. Thus, S6K2 but not S6K1 mediates prosurvival/chemoresistance signalling.  \n",
       "963                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Although casein kinase Iepsilon (CKIepsilon) has been shown to regulate the Wnt signaling pathway positively, its mode of action is not clear. In this study we show that CKIepsilon activates the Wnt signaling pathway in co-operation with Dvl. CKIepsilon and Axin associated with different sites of Dvl, and CKIepsilon and Dvl interacted with distinct regions on Axin. Therefore, these three proteins formed a ternary complex. Either low expression of Dvl or CKIepsilon alone did not accumulate beta-catenin, but their co-expression accumulated greatly. Dvl and CKIepsilon activated the transcriptional activity of T cell factor (Tcf) synergistically. Although the Dvl mutant that binds to Axin but not to CKIepsilon activated Tcf, it did not synergize with CKIepsilon. Another Dvl mutant that does not bind to Axin did not activate Tcf irrespective of the presence of CKIepsilon. Furthermore, Dvl and CKIepsilon co-operatively induced axis duplication of Xenopus embryos. These results indicate that Dvl and CKIepsilon synergistically activated the Wnt signaling pathway and that the binding of the complex of Dvl and CKIepsilon to Axin is necessary for their synergistic action.  \n",
       "2228                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Cancer therapies directed at specific molecular targets in signaling pathways of cancer cells, such as tamoxifen, aromatase inhibitors and trastuzumab, have proven useful for treatment of advanced breast cancers. However, increased risk of endometrial cancer with long-term tamoxifen administration and of bone fracture due to osteoporosis in postmenopausal women undergoing aromatase inhibitor therapy are recognized side effects. These side effects as well as drug resistance make it necessary to search for novel molecular targets for drugs on the basis of well-characterized mechanisms of action.  \n",
       "3171                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Fidelity of chromosome segregation is ensured by a tension-dependent error correction system that prevents stabilization of incorrect chromosome-microtubule attachments. Unattached or incorrectly attached chromosomes also activate the spindle assembly checkpoint, thus delaying mitotic exit until all chromosomes are bioriented. The Aurora B kinase is widely recognized as a component of error correction. Conversely, its role in the checkpoint is controversial. Here, we report an analysis of the role of Aurora B in the spindle checkpoint under conditions believed to uncouple the effects of Aurora B inhibition on the checkpoint from those on error correction. Partial inhibition of several checkpoint and kinetochore components, including Mps1 and Ndc80, strongly synergizes with inhibition of Aurora B activity and dramatically affects the ability of cells to arrest in mitosis in the presence of spindle poisons. Thus, Aurora B might contribute to spindle checkpoint signalling independently of error correction. Our results support a model in which Aurora B is at the apex of a signalling pyramid whose sensory apparatus promotes the concomitant activation of error correction and checkpoint signalling pathways.  \n",
       "282                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               The Hippo pathway is crucial in organ size control, and its dysregulation contributes to tumorigenesis. However, upstream signals that regulate the mammalian Hippo pathway have remained elusive. Here, we report that the Hippo pathway is regulated by G-protein-coupled receptor (GPCR) signaling. Serum-borne lysophosphatidic acid (LPA) and sphingosine 1-phosphophate (S1P) act through G12/13-coupled receptors to inhibit the Hippo pathway kinases Lats1/2, thereby activating YAP and TAZ transcription coactivators, which are oncoproteins repressed by Lats1/2. YAP and TAZ are involved in LPA-induced gene expression, cell migration, and proliferation. In contrast, stimulation of Gs-coupled receptors by glucagon or epinephrine activates Lats1/2 kinase activity, thereby inhibiting YAP function. Thus, GPCR signaling can either activate or inhibit the Hippo-YAP pathway depending on the coupled G protein. Our study identifies extracellular diffusible signals that modulate the Hippo pathway and also establishes the Hippo-YAP pathway as a critical signaling branch downstream of GPCR.  \n",
       "1683                                                                                                                                                                                                                                                                                                                                                                                                                                               Signal transducers and activators of transcription (STATs) play a pleomorphic role in signal transduction, similarly to an oncogene. Suppressors of cytokine signaling (SOCS) inhibit STAT pathways. In breast cancer, little is known about the correlation among STATs, SOCS, and clinicopathological/biological features. Therefore, we investigated p-STAT3 (activated form of STAT3) and SOCS-1/3 expression, and clarified their correlation. Immunohistochemical staining for p-STAT3 antigen was performed in 74 surgically resected primary breast cancers. Real-time RT-PCR was used to measure mRNA expression of SOCS-1 and SOCS-3. There were no significant correlations between p-STAT3 expression and clinicopathological/biological features. SOCS-3 mRNA expression in the lymph node-positive group was significantly lower than that in the negative group (p=0.013). Among three groups divided based on the number of involved lymph nodes (node-negative group, 1-3 involved nodes group, 4 or more involved nodes group), the group with 4 or more involved nodes had the lowest expression of SOCS-3 (p=0.043). Correlations were not seen between SOCS-1 and SOCS-3 expression and other clinicopathological/biological features, except for blood vessel invasion. There were no statistical correlations between either SOCS-1 or SOCS-3 mRNA expression and p-STAT3 expression. Reduced expression of SOCS-3 is closely related to lymph node metastasis. Therefore, SOCS-3 may be a good predictor for lymph node metastasis.  \n",
       "3361                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Cysteine is the most intrinsically nucleophilic amino acid in proteins, where its reactivity is tuned to perform diverse biochemical functions. The absence of a consensus sequence that defines functional cysteines in proteins has hindered their discovery and characterization. Here we describe a proteomics method to profile quantitatively the intrinsic reactivity of cysteine residues en masse directly in native biological systems. Hyper-reactivity was a rare feature among cysteines and it was found to specify a wide range of activities, including nucleophilic and reductive catalysis and sites of oxidative modification. Hyper-reactive cysteines were identified in several proteins of uncharacterized function, including a residue conserved across eukaryotic phylogeny that we show is required for yeast viability and is involved in iron-sulphur protein biogenesis. We also demonstrate that quantitative reactivity profiling can form the basis for screening and functional assignment of cysteines in computationally designed proteins, where it discriminated catalytically active from inactive cysteine hydrolase designs.  \n",
       "465                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 During interphase in Drosophila neuroblasts, the Centrobin (CNB)-positive daughter centriole retains pericentriolar material (PCM) and organizes an aster that is a key determinant of the orientation of cell division. Here we show that daughter centrioles depleted of CNB cannot fulfil this function whereas mother centrioles that carry ectopic CNB can. CNB co-precipitates with a set of centrosomal proteins that include -TUB, ANA2, CNN, SAS-4, ASL, DGRIP71, POLO and SAS-6. Following chemical inhibition of POLO or removal of three POLO phosphorylation sites present in CNB, the interphase microtubule aster is lost. These results demonstrate that centriolar CNB localization is both necessary and sufficient to enable centrioles to retain PCM and organize the interphase aster in Drosophila neuroblasts. They also reveal an interphase function for POLO in this process that seems to have co-opted part of the protein network involved in mitotic centrosome maturation.  \n",
       "158   The function of many protein kinases is controlled by the phosphorylation of a critical tyrosine residue in the activation loop. Dual specificity tyrosine-phosphorylation-regulated kinases (DYRKs) autophosphorylate on this tyrosine residue but phosphorylate substrates on aliphatic amino acids. This study addresses the mechanism of dual specificity kinase activity in DYRK1A and related kinases. Tyrosine autophosphorylation of DYRK1A occurred rapidly during in vitro translation and did not depend on the non-catalytic domains or other proteins. Expression in bacteria as well as in mammalian cells revealed that tyrosine kinase activity of DYRK1A is not restricted to the co-translational autophosphorylation in the activation loop. Moreover, mature DYRK1A was still capable of tyrosine autophosphorylation. Point mutants of DYRK1A and DYRK2 lacking the activation loop tyrosine showed enhanced tyrosine kinase activity. A series of structurally diverse DYRK1A inhibitors was used to pharmacologically distinguish different conformational states of the catalytic domain that are hypothesized to account for the dual specificity kinase activity. All tested compounds inhibited substrate phosphorylation with higher potency than autophosphorylation but none of the tested inhibitors differentially inhibited threonine and tyrosine kinase activity. Finally, the related cyclin-dependent kinase-like kinases (CLKs), which lack the activation loop tyrosine, autophosphorylated on tyrosine both in vitro and in living cells. We propose a model of DYRK autoactivation in which tyrosine autophosphorylation in the activation loop stabilizes a conformation of the catalytic domain with enhanced serine/threonine kinase activity without disabling tyrosine phosphorylation. The mechanism of dual specificity kinase activity probably applies to related serine/threonine kinases that depend on tyrosine autophosphorylation for maturation.  "
      ]
     },
     "execution_count": 26,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "\n",
    "pd.set_option('display.max_columns', None)\n",
    "pd.set_option('display.max_colwidth', 10000)\n",
    "pd.set_option('display.max_rows', 100)\n",
    "\n",
    "data.query('entityMentionsCount == 0')[['participants','pubmedabstract' ]].sample(n=10)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "      <th>hasTriggerWord</th>\n",
       "      <th>entityMentionsCount</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>2503510</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2503513</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>1796163</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]</td>\n",
       "      <td>25500533</td>\n",
       "      <td>None</td>\n",
       "      <td>LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1 (CK1) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1000</th>\n",
       "      <td>1160297</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1001</th>\n",
       "      <td>1160335</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]</td>\n",
       "      <td>20856200</td>\n",
       "      <td>None</td>\n",
       "      <td>The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1002</th>\n",
       "      <td>1160459</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1003</th>\n",
       "      <td>1160465</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1004</th>\n",
       "      <td>1160473</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]</td>\n",
       "      <td>20890306</td>\n",
       "      <td>None</td>\n",
       "      <td>Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.</td>\n",
       "      <td>True</td>\n",
       "      <td>True</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1005</th>\n",
       "      <td>2665902</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': 'Q5F298', 'alias': [['rpb1_mouse'], ['DNA-directed RNA polymerase II subunit RPB1'], ['Polr2a'], ['Rpii215'], ['Rpo2-1'], ['DNA-directed RNA polymerase II subunit A'], ['DNA-directed RNA polymerase III largest subunit']]}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]</td>\n",
       "      <td>20861839</td>\n",
       "      <td>Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.</td>\n",
       "      <td>Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (PolII). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the PolII carboxy-terminal domain (CTD) Ser5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel -helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer5-Pro6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1006</th>\n",
       "      <td>2665906</td>\n",
       "      <td>dephosphorylation</td>\n",
       "      <td>false</td>\n",
       "      <td>[{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]</td>\n",
       "      <td>20861839</td>\n",
       "      <td>Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.</td>\n",
       "      <td>Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (PolII). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the PolII carboxy-terminal domain (CTD) Ser5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel -helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer5-Pro6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.</td>\n",
       "      <td>True</td>\n",
       "      <td>False</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      interactionId    interactionType isNegative  \\\n",
       "0           2503510    phosphorylation      false   \n",
       "1           2503513    phosphorylation      false   \n",
       "10          1796163    phosphorylation      false   \n",
       "1000        1160297    phosphorylation      false   \n",
       "1001        1160335    phosphorylation      false   \n",
       "1002        1160459    phosphorylation      false   \n",
       "1003        1160465    phosphorylation      false   \n",
       "1004        1160473    phosphorylation      false   \n",
       "1005        2665902  dephosphorylation      false   \n",
       "1006        2665906  dephosphorylation      false   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                               participants  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                   [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}]   \n",
       "1                       [{'uniprotid': 'P43405', 'alias': [['ksyk_human'], ['Tyrosine-protein kinase SYK'], ['SYK'], ['Spleen tyrosine kinase'], ['p72-Syk']]}, {'uniprotid': 'Q9BSZ5', 'alias': [['asc_human'], ['Apoptosis-associated speck-like protein containing a CARD'], ['PYD and CARD domain-containing protein'], ['Target of methylation-induced silencing 1'], ['Caspase recruitment domain-containing protein 5'], ['ASC'], ['CARD5'], ['TMS1'], ['PYCARD']]}]   \n",
       "10                                                                                                                                                                                                   [{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]   \n",
       "1000                                                                                                                                                                                                                                                 [{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]   \n",
       "1001                                                                                                                                                               [{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]   \n",
       "1002  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1003  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1004  [{'uniprotid': 'Q15153', 'alias': [['plk1_human'], ['Serine/threonine-protein kinase PLK1'], ['Polo-like kinase 1'], ['Serine/threonine-protein kinase 13'], ['PLK1'], ['PLK']]}, {'uniprotid': 'Q6IBR4', 'alias': [['fadd_human'], ['FAS-associated death domain protein'], ['FAS-associating death domain-containing protein'], ['Mediator of receptor induced toxicity'], ['FADD'], ['MORT1'], ['Protein FADD'], ['GIG3'], ['Growth-inhibiting gene 3 protein']]}]   \n",
       "1005                                                           [{'uniprotid': 'Q5F298', 'alias': [['rpb1_mouse'], ['DNA-directed RNA polymerase II subunit RPB1'], ['Polr2a'], ['Rpii215'], ['Rpo2-1'], ['DNA-directed RNA polymerase II subunit A'], ['DNA-directed RNA polymerase III largest subunit']]}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]   \n",
       "1006                                                                                                                                                                                                                                                                    [{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q9NP77-1', 'alias': [['q9np77-1'], ['RNA polymerase II subunit A C-terminal domain phosphatase SSU72'], ['SSU72'], ['HSPC182'], ['PNAS-120']]}]   \n",
       "\n",
       "      pubmedId  \\\n",
       "0     25605870   \n",
       "1     25605870   \n",
       "10    25500533   \n",
       "1000  20856200   \n",
       "1001  20856200   \n",
       "1002  20890306   \n",
       "1003  20890306   \n",
       "1004  20890306   \n",
       "1005  20861839   \n",
       "1006  20861839   \n",
       "\n",
       "                                                                     pubmedTitle  \\\n",
       "0                                                                           None   \n",
       "1                                                                           None   \n",
       "10                                                                          None   \n",
       "1000                                                                        None   \n",
       "1001                                                                        None   \n",
       "1002                                                                        None   \n",
       "1003                                                                        None   \n",
       "1004                                                                        None   \n",
       "1005  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.   \n",
       "1006  Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  pubmedabstract  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                 NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                 NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          LRRK2, a gene relevant to Parkinson's disease, encodes a scaffolding protein with both GTPase and kinase activities. LRRK2 protein is itself phosphorylated and therefore is subject to regulation by cell signalling; however, the kinase(s) responsible for this event have not been definitively identified. Here using an unbiased siRNA kinome screen, we identify and validate casein kinase 1 (CK1) as being responsible for LRRK2 phosphorylation, including in the adult mouse striatum. We further show that LRRK2 recruitment to TGN46-positive Golgi-derived vesicles is modulated by constitutive LRRK2 phosphorylation by CK1. These effects are mediated by differential protein interactions of LRRK2 with a guanine nucleotide exchange factor, ARHGEF7. These pathways are therefore likely involved in the physiological maintenance of the Golgi in cells, which may play a role in the pathogenesis of Parkinson's disease.    \n",
       "1000                                                                                                                                                                                                                                                                                                                                                               The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.   \n",
       "1001                                                                                                                                                                                                                                                                                                                                                               The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform type-specific AKT-driven function. By implication, study of AKT signaling should optimally be conducted in an appropriate intracellular environment. Prognosis in soft-tissue sarcoma (STS), the aggressive malignancies of mesenchymal origin, is poor, reflecting our modest ability to control metastasis, an effort hampered by lack of insight into molecular mechanisms driving STS progression and dissemination. We examined the impact of the cancer progression-relevant AKT pathway on the mesenchymal tumor cell internal milieu. We demonstrate that AKT1 activation induces STS cell motility and invasiveness at least partially through a novel interaction with the intermediate filament vimentin (Vim). The binding of AKT (tail region) to Vim (head region) results in Vim Ser39 phosphorylation enhancing the ability of Vim to induce motility and invasion while protecting Vim from caspase-induced proteolysis. Moreover, vimentin phosphorylation was shown to enhance tumor and metastasis growth in vivo. Insights into this mesenchymal-related molecular mechanism may facilitate the development of critically lacking therapeutic options for these devastating malignancies.   \n",
       "1002                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1003                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1004                                                                                                                                                                                                                                                                                                                                                                   Phosphorylation of the Fas-associated death domain (FADD) protein sensitizes cancer cells to various chemotherapeutics. However, the molecular mechanism underlying chemosensitization by phosphorylated FADD (P-FADD) is poorly understood. In this study, we describe the physical interactions and functional interplay between Polo-like kinase 1 (Plk1) and FADD. Plk1 phosphorylates FADD at Ser-194 in response to treatment with taxol. Overexpression of a phosphorylation-mimicking mutant, FADD S194D, caused degradation of Plk1 in an ubiquitin-independent manner, and delayed cytokinesis, consistent with the expected cellular phenotype of Plk1 deficiency. This demonstrates that Plk1 is regulated via a negative feedback loop by its substrate, FADD. Overexpression of FADD S194D sensitized HeLa cells to a low dose of taxol independently of caspase activation, whereas overexpression of FADD S194D resulted in caspase activation in response to a high dose of taxol. Therefore, we examined whether the death potential of P-FADD affected Plk1-mediated tumorigenesis. Transfection of FADD S194D inhibited colony formation by Plk1-overexpressing HeLa cells (HeLa-Plk1). Moreover, overexpression of FADD S194D suppressed tumorigenesis in nude mice xenografted with HeLa-Plk1. Therefore, this study reports the first in vivo validation of tumor-suppressing activity of P-FADD. Collectively, our data demonstrate that in response to taxol, Plk1 endows death-promoting and tumor-suppressor functions to its substrate, FADD.   \n",
       "1005  Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (PolII). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the PolII carboxy-terminal domain (CTD) Ser5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel -helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer5-Pro6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.   \n",
       "1006  Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs); it also participates in transcription initiation and termination by RNA polymerase II (PolII). Symplekin mediates interactions between many different proteins in this machinery, although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the PolII carboxy-terminal domain (CTD) Ser5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel -helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase, although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer5-Pro6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations. Although the active site of Ssu72 is about 25 from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.   \n",
       "\n",
       "      lessThanThreshold  hasTriggerWord  entityMentionsCount  \n",
       "0                  True            True                    1  \n",
       "1                  True            True                    2  \n",
       "10                 True            True                    3  \n",
       "1000               True            True                    1  \n",
       "1001               True            True                    4  \n",
       "1002               True            True                    7  \n",
       "1003               True            True                    7  \n",
       "1004               True            True                    7  \n",
       "1005               True           False                    2  \n",
       "1006               True           False                    1  "
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.head(n=10)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Okay.. looks like it is only a case of the names of the participants not matching the names of the alias used in the abstract.. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Data Engineering"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Add more negative samples"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [],
   "source": [
    "import uuid\n",
    "unique_pubmeds = data[\"pubmedId\"].unique()\n",
    "data_fake = pd.DataFrame(columns=data.columns)\n",
    "num_fake_records = int( .30 * len(data))\n",
    "#TODO: Randomise this, biased via\n",
    "for u in unique_pubmeds:\n",
    "    fake_records = pd.DataFrame(data[ data.pubmedId != u]  ) \n",
    "    fake_records.loc[:, \"interactionId\"] = \"Fake_\" + str(uuid.uuid4() ) + \"_\" + fake_records.interactionId.astype(str) \n",
    "    fake_records.loc[:,\"isNegative\"] = 'True' \n",
    "    ## Copy of the pubmeid abtract and the title from a id\n",
    "    fake_records.loc[:,\"pubmedId\"] = u\n",
    "    fake_records.loc[:, \"pubmedTitle\"] =  data[ data.pubmedId == u].iloc[0][\"pubmedTitle\"]\n",
    "    fake_records.loc[:, \"pubmedabstract\"] =  data[ data.pubmedId == u].iloc[0][\"pubmedabstract\"]\n",
    "    \n",
    "    \n",
    "    data_fake = data_fake.append(fake_records, ignore_index=True)\n",
    "    if len(data_fake) > num_fake_records:\n",
    "        break\n",
    "  \n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>interactionId</th>\n",
       "      <th>interactionType</th>\n",
       "      <th>isNegative</th>\n",
       "      <th>participants</th>\n",
       "      <th>pubmedId</th>\n",
       "      <th>pubmedTitle</th>\n",
       "      <th>pubmedabstract</th>\n",
       "      <th>lessThanThreshold</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1796163</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>[{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1160297</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>[{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1160335</td>\n",
       "      <td>phosphorylation</td>\n",
       "      <td>True</td>\n",
       "      <td>[{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]</td>\n",
       "      <td>25605870</td>\n",
       "      <td>None</td>\n",
       "      <td>NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.</td>\n",
       "      <td>True</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                       interactionId  interactionType  \\\n",
       "0  Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1796163  phosphorylation   \n",
       "1  Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1160297  phosphorylation   \n",
       "2  Fake_b18816a7-1a7d-4915-94f2-a8c6d67fd4c9_1160335  phosphorylation   \n",
       "\n",
       "  isNegative  \\\n",
       "0       True   \n",
       "1       True   \n",
       "2       True   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                               participants  \\\n",
       "0                                    [{'uniprotid': 'Q8WUB1', 'alias': [['kc1g2_human'], ['Casein kinase I isoform gamma-2'], ['CK1G2'], ['CSNK1G2']]}, {'uniprotid': 'Q6ZS50', 'alias': [['lrrk2_human'], ['Leucine-rich repeat serine/threonine-protein kinase 2'], ['LRRK2'], ['PARK8'], ['Dardarin']]}]   \n",
       "1                                                                                    [{'uniprotid': None, 'alias': None}, {'uniprotid': 'Q05BV0', 'alias': [['akt2_human'], ['RAC-beta serine/threonine-protein kinase'], ['AKT2'], ['RAC-PK-beta'], ['Protein kinase Akt-2'], ['Protein kinase B beta']]}]   \n",
       "2  [{'uniprotid': 'B7Z5R1', 'alias': [['akt1_human'], ['RAC-alpha serine/threonine-protein kinase'], ['AKT1'], ['PKB'], ['RAC'], ['RAC-PK-alpha'], ['Protein kinase B'], ['Proto-oncogene c-Akt'], ['Protein kinase B alpha']]}, {'uniprotid': 'Q9NTM3', 'alias': [['vime_human'], ['Vimentin'], ['VIM']]}]   \n",
       "\n",
       "   pubmedId pubmedTitle  \\\n",
       "0  25605870        None   \n",
       "1  25605870        None   \n",
       "2  25605870        None   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   pubmedabstract  \\\n",
       "0  NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "1  NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "2  NLRP3 is the most crucial member of the NLR family, as it detects the existence of pathogen invasion and self-derived molecules associated with cellular damage. Several studies have reported that excessive NLRP3 inflammasome-mediated caspase-1 activation is a key factor in the development of diseases. Recent studies have reported that Syk is involved in pathogen-induced NLRP3 inflammasome activation; however, the detailed mechanism linking Syk to NLRP3 inflammasome remains unclear. In this study, we showed that Syk mediates NLRP3 stimuli-induced processing of procaspase-1 and the consequent activation of caspase-1. Moreover, the kinase activity of Syk is required to potentiate caspase-1 activation in a reconstituted NLRP3 inflammasome system in HEK293T cells. The adaptor protein ASC bridges NLRP3 with the effector protein caspase-1. Herein, we find that Syk can associate directly with ASC and NLRP3 by its kinase domain but interact indirectly with procaspase-1. Syk can phosphorylate ASC at Y146 and Y187 residues, and the phosphorylation of both residues is critical to enhance ASC oligomerization and the recruitment of procaspase-1. Together, our results reveal a new molecular pathway through which Syk promotes NLRP3 inflammasome formation, resulting from the phosphorylation of ASC. Thus, the control of Syk activity might be effective to modulate NLRP3 inflammasome activation and treat NLRP3-related immune diseases.   \n",
       "\n",
       "  lessThanThreshold  \n",
       "0              True  \n",
       "1              True  \n",
       "2              True  "
      ]
     },
     "execution_count": 123,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_fake.head(n=3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The total number of records including fake records 4069\n"
     ]
    }
   ],
   "source": [
    "data_final = data.append(data_fake, ignore_index=True)\n",
    "print(\"The total number of records including fake records {}\".format(data_final.shape[0]))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_final = data_final.drop('lessThanThreshold' , axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 129,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_final.to_json(\"formatteddata.json\")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 1
}
